In contrast, antibodies to cit-TNC17 were present in 100% of the RA sera, while antibodies to cit-TNC56, cit-TNC22, and cit-TNC45 were present in 53%, 35%, and 29% of the RA sera, respectively. Here, CIT is linked to rheumatoid arthritis.